These results effectively verified the superiority of bLP-mediated TECA strategy on enhancing second nanoparticles accessibility to the cancer cells in tumor, which was primarily owing to the effective D-bLP-meditated TSM remodeling, as well as the small particle size and bioinspired properties of M-bLP. This evidence concerns the gene DYNLRB1 and neoplasm.